SCHEMBL5243149

SCHEMBL5243149

CCCCn1c(=O)[nH]c2cc(Nc3ccccc3)ccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 1/20 0.48
ERCC1 P07992 1/20 0.47
DNASE1 P24855 1/20 0.47
FEN1 P39748 1/20 0.47
ERCC4 Q92889 1/20 0.47
APP P05067 1/20 0.47
POLB P06746 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
LMNA P02545 1/20 0.45
HPGD P15428 1/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
GAA P10253 2/20 0.44
MEN1 O00255 1/20 0.43
CYP1A2 P05177 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5240132 0.96 RAB9A (0.47) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5240605 0.95 RAB9A (0.46) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5242811 0.87 POLB (0.51) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5242591 0.87 MPO (0.49) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5242487 0.85 ERCC1 (0.49) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL14339577 0.85 ERCC1 (0.49) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5243422 0.84 ERCC1 (0.46) ERCC1DNASE1FEN1ERCC4APP
SCHEMBL5244668 0.84 ERCC1 (0.46) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5243499 0.84 KMT2A (0.48) RAB9AERCC1DNASE1FEN1ERCC4
SCHEMBL5242189 0.84 HTR7 (0.55) LMNAMAPK1MEN1CYP1A2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115644-B2 Heterocyclic compounds BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-10-03 US claimed
EP-1539708-B1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2007-12-26 EP disclosed
EP-1539708-B1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMA (US) 2007-12-26 EP disclosed
US-7115644-B2 Heterocyclic compounds BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2006-10-03 US disclosed
EP-1539708-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2005-06-15 EP disclosed
WO-2004024699-A1 BENZIMIDAZOLONES AND THEIR USE AS CYTOKINE INHIBITORS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2004-03-25 WO disclosed